Old Web
English
Sign In
Acemap
>
authorDetail
>
Alexander A. Cohen
Alexander A. Cohen
Huazhong University of Science and Technology
Medicine
Venous thrombosis
Anticoagulant
Thrombosis
Anesthesia
3
Papers
629
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
2014
The Lancet Haematology
Martin H. Prins
Anthonie W. A. Lensing
Tim A. Brighton
Roger M. Lyons
Jeffrey Rehm
Mila Trajanovic
Bruce L. Davidson
Jan Beyer-Westendorf
Akos F. Pap
Scott D. Berkowitz
Alexander A. Cohen
Michael J. Kovacs
Philip S. Wells
Paolo Prandoni
Show All
Source
Cite
Save
Citations (195)
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
2010
Thrombosis and Haemostasis
Gary E. Raskob
Alexander A. Cohen
Bengt I. Eriksson
David Puskas
Minggao Shi
Tomas S Bocanegra
Jeffrey I. Weitz
Show All
Source
Cite
Save
Citations (131)
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein–DVT Dose-Ranging Study
2008
Blood
Harry R. Buller
Anthonie W. A. Lensing
Martin H. Prins
Giancarlo Agnelli
Alexander A. Cohen
Alexander Gallus
Frank Misselwitz
Gary E. Raskob
Sebastian Schellong
Annelise Segers
Show All
Source
Cite
Save
Citations (303)
1